Visen Pharmaceuticals

Visen Pharmaceuticals

Latest funding
$150,000,000
Venture capital (Series B) - 2021
OrbiMed Cormorant Asset Management Vivo Capital +7
Team Size
1–10
Employees
Location
Headquarters
$150,000,000 Venture capital (Series B)
ChinaMoneyNetwork

Sequoia China Leads $150 Million Round In Drug Developer Visen Pharma – China Money Network